Oncternal Therapeutics (ONCT) Stock Chart & Stock Price History → Does this make you sick? (From Allegiance Gold) (Ad) Free ONCT Stock Alerts $8.47 +0.29 (+3.55%) (As of 01:39 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Oncternal Therapeutics Stock Price Performance5 Day Performance-2.64%1 Month Performance-9.89%3 Month Performance-5.78%6 Month Performance+35.09%Year-To-Date Performance-21.02%1 Year Performance+48.08% Receive ONCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action ONCT Stock Chart for Monday, May, 13, 2024 ONCT Chart by TradingView Oncternal Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$8.86$8.80-0.68%$9.00$8.102,568 shs$26.05 million05/09/2024$8.70$8.86+1.84%$8.86$8.641,695 shs$26.23 million05/08/2024$8.52$8.70+2.11%$9.12$8.70737 shs$25.75 million05/07/2024$9.00$8.52-5.33%$9.06$8.2711,097 shs$25.22 million05/06/2024$8.75$9.00+2.92%$9.01$8.853,481 shs$26.64 million05/03/2024$8.75$8.26-5.55%$8.88$8.26337 shs$24.45 million Get the Latest News and Ratings for ONCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$8.00$8.75+9.31%$8.80$7.9810,072 shs$25.89 million05/01/2024$8.31$8.00-3.73%$8.38$8.004,418 shs$23.68 million04/30/2024$8.48$8.31-2.00%$8.50$8.152,594 shs$22.35 million04/29/2024$8.29$8.48+2.29%$8.96$8.402,659 shs$22.81 million04/26/2024$8.25$8.29+0.48%$8.29$8.001,441 shs$22.30 million04/25/2024$8.61$8.25-4.18%$8.99$8.206,862 shs$22.19 million04/24/2024$8.77$8.61-1.77%$8.80$8.521,600 shs$23.16 million04/23/2024$8.55$8.77+2.51%$9.00$8.53955 shs$23.58 million04/22/2024$8.86$8.55-3.50%$9.08$8.451,657 shs$23 million04/19/2024$8.60$9.15+6.40%$9.15$8.604,539 shs$24.61 million04/18/2024$8.71$8.60-1.26%$8.88$8.132,821 shs$23.13 million04/17/2024$8.69$8.71+0.23%$9.14$8.624,002 shs$23.42 million04/16/2024$8.80$8.69-1.25%$9.29$8.692,318 shs$23.38 million04/15/2024$9.40$8.80-6.38%$9.36$8.699,220 shs$23.67 million04/12/2024$8.94$9.31+4.14%$9.48$8.885,093 shs$25.04 million04/11/2024$8.70$8.94+2.79%$9.28$8.7515,627 shs$24.05 million04/10/2024$8.65$8.70+0.55%$9.25$8.6413,106 shs$23.40 million04/09/2024$8.65$8.65$8.99$8.1821,657 shs$23.27 million04/08/2024$8.65$8.65$9.00$8.655,591 shs$23.27 million04/05/2024$8.80$8.65-1.70%$8.81$8.339,342 shs$23.27 million04/04/2024$9.00$8.80-2.22%$9.26$8.499,784 shs$23.67 million04/03/2024$9.27$9.00-2.91%$9.27$8.961,865 shs$24.21 million04/02/2024$9.30$9.27-0.32%$9.85$9.274,771 shs$24.94 million04/01/2024$9.00$9.30+3.33%$9.82$8.995,129 shs$25.02 million03/29/2024$9.00$9.00$9.25$8.0014,521 shs$24.21 million03/28/2024$8.20$9.00+9.76%$9.25$8.0014,511 shs$24.21 million03/27/2024$8.11$8.20+1.11%$8.28$8.082,686 shs$22.06 million03/26/2024$8.21$8.11-1.22%$8.27$8.051,183 shs$21.82 million03/25/2024$8.22$8.21-0.12%$8.50$8.164,285 shs$22.09 million03/22/2024$7.96$8.22+3.27%$8.48$7.923,753 shs$22.11 million03/21/2024$8.18$7.96-2.69%$8.30$7.816,327 shs$21.41 million03/20/2024$7.88$8.18+3.81%$8.50$7.856,635 shs$22.00 million03/19/2024$7.80$7.88+1.03%$7.90$7.801,625 shs$21.20 million03/18/2024$8.02$7.80-2.74%$8.31$7.8018,252 shs$20.98 millionYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad)While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action03/15/2024$7.89$8.02+1.71%$8.05$7.485,712 shs$21.57 million03/14/2024$9.05$7.89-12.87%$9.18$7.8223,878 shs$21.20 million03/13/2024$9.00$9.05+0.56%$9.33$9.002,342 shs$24.34 million03/12/2024$9.60$9.00-6.25%$9.65$9.005,469 shs$26.64 million03/11/2024$9.59$9.60+0.10%$9.96$9.602,261 shs$28.42 million03/08/2024$9.25$9.59+3.68%$9.59$9.236,310 shs$28.29 million03/07/2024$9.55$9.25-3.14%$9.61$9.2411,601 shs$27.29 million03/06/2024$9.50$9.55+0.53%$10.00$9.4513,744 shs$28.17 million03/05/2024$10.15$9.50-6.40%$10.27$9.2513,367 shs$28.03 million03/04/2024$10.03$10.15+1.20%$10.60$10.0010,974 shs$29.92 million03/01/2024$9.30$10.03+7.85%$10.61$9.3043,855 shs$29.59 million02/29/2024$9.46$9.30-1.70%$9.66$9.305,567 shs$27.44 million02/28/2024$9.66$9.46-2.07%$9.85$9.222,585 shs$27.91 million02/27/2024$9.26$9.66+4.32%$9.66$9.272,126 shs$28.50 million02/26/2024$9.04$9.26+2.43%$9.68$9.009,355 shs$27.32 million02/23/2024$9.20$9.04-1.74%$9.25$9.033,295 shs$26.67 million02/22/2024$9.01$9.20+2.11%$9.40$8.7714,304 shs$27.14 million02/21/2024$8.60$9.01+4.77%$9.10$8.522,536 shs$26.58 million02/20/2024$8.42$8.60+2.14%$8.77$8.439,325 shs$25.37 million02/19/2024$8.42$8.42$8.99$8.3713,300 shs$24.84 million02/16/2024$8.99$8.42-6.34%$8.99$8.3713,319 shs$24.84 million02/15/2024$9.18$8.99-2.07%$9.20$8.994,289 shs$26.50 million02/14/2024$8.99$9.18+2.11%$9.29$8.998,078 shs$27.06 million02/13/2024$9.70$8.99-7.27%$9.68$8.9913,346 shs$26.52 million02/12/2024$9.88$9.70-1.87%$9.89$9.4614,672 shs$28.60 million Related Companies: ITRM Stock Price Chart QLI Stock Price Chart FBRX Stock Price Chart LUMO Stock Price Chart BIOR Stock Price Chart LPCN Stock Price Chart UBX Stock Price Chart LSTA Stock Price Chart ACST Stock Price Chart TXMD Stock Price Chart Receive ONCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ONCT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncternal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.